Teva Pharmaceutical Industries

TEVA

TEL AVIV STOCK EXCHANGEHealth Care

Income Statement

Total Revenue$16.54B

Gross Profit$8.06B

Operating Income$-315M

EBITDA$1.08B

EBIT$17M

Pre-tax Income$1.37B

Net Income$-1.64B

Cash Equivalent$2.97B

Total Debt$19.05B

Book Value$6.55B

Book Value Per Share5.80

Return on Equity (ROE)-30.50%

Return on Assets (ROA)-4.17%

Return on Invested Capital (ROI)-7.08%

Net Profit Margin-9.91%

Current Ratio0.98

Quick Ratio0.67

Long-Term Debt / Equity2.98